Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: PSE 120 mg, CM 8 mg, Atr 0.36 mg
Total 0 results
Nothing found
Sponsors and Collaborators
Etan Orgel
Daniela Pacella - University of Naples Federico II, Naples
the people hospital of Linzhi
National Institute of Cardiovascular Diseases, Bangladesh
Bassam Abdulkarim
Direction Interarmées du Service de Santé des Armées (DIASS) de Cayenne, French Guiana
ADOR - Territorial Support Network, Device and Tools for Primary Care Teams
Sublimity Therapeutics Holdco Limited
Centro Universitário Franciscano
The Australia-Israel Scientific Exchange Foundation (AISEF)
Hospitales Universitarios Virgen del Rocío
Ouctomes Research Consortium, Cleveland Clinic, Ohio, USA
Sahachat Aueyingsak
Glasgow Western Infirmary
ECMC
Åke Wibergs Stiftelse
IRCCS Istituto Auxologico Italiano, Milano, Italy
ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITRO
AlpinARC
Dr Philippe METELLUS
View Full List
Medical Conditions
Failed Open Reduction Internal Fixation (ORIF) of a Radial Head Fracture
Genetic Risk Factor
Implanted With Any Currently (and Any Future) FDA-approved Medtronic ICD or CRT Device
Very Long Chain Acyl Coa Dehydrogenase Deficiency
Patients With Leptomeningeal Disease
Legal History
Initiation of Depo-Provera (DMPA)
Degenerative Spondylolisthesis G1
Panniculectomy
Pancreaticoduodenectomy
Transitional Cell Carcinoma of Renal Pelvis
Adult Patients Undergoing Surgery That Requires General Anesthesia
Bladder Cancer TNM Staging Primary Tumor (T) T2B
Value-Based Health Insurance
Hyperprolinemia
Orthopaedic Disorders
Interviews
Eosinophil Blood Count
Progression to PD-1 Antibody
Ability to Swim 100m Independent Freestyle
View Full List
Drug Interventions
IV rtPA (intravenous recombinant plasminogen activator)
Gefitinib
Paliperidone palmitate
UFUR and Iressa
HBM4003 and Triprilimab
Epirubicin hydrochloride
0% N2O
6% hetastarch
5-Fluoro-uracil
Erythropoietin
ASP8062
Mepivacaine
Cefuroxime 750mg oral
Injectable Insulin
Prasugrel
Antibiotic treatment
Metoclopramide + dexamethasone
Omeprazole 20mg
Nimotuzumab
ATG-008 30 mg, orally, QD, each 4 week (28-day) a cycle
View Full List
CROs by country
Contract Research Organizations in Argentina
Contract Research Organizations in Congo
Contract Research Organizations in Congo, DR of
Contract Research Organizations in Djibouti
Contract Research Organizations in Ecuador
Contract Research Organizations in Equatorial Guinea
Contract Research Organizations in Ireland
Contract Research Organizations in Israel
Contract Research Organizations in Jordan
Contract Research Organizations in Liberia
Contract Research Organizations in Nigeria
Contract Research Organizations in Thailand
Contract Research Organizations in Venezuela
CRO list by country
CROs in Canada
JSS Medical Research
Prohealth
Axon
PPD
TRIO
Emergo Group
PSI
Biotrial
Premier Research
Vantage BioTrials
All CROs in Canada
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe